ARTICLE | Company News
InterMune, Protein Design Labs deal
August 20, 2001 7:00 AM UTC
ITMN accepted from PDLI a humanized version of ITMN's monoclonal antibody against the PcrV surface protein of Pseudomonas aeruginosa under the companies' December 2000 deal (see BioCentury Dec. 20, 20...